26/02/2015 - 22:58 The Food and Drug Administration has approved the antibacterial drug ceftazidime- avibactam (Avycaz) on Feb. 25 for complicated intra-abdominal infect... More » Visit websiteField of Interest: Gastroentero...Categories: SN || NewsEM || FDA and CDCEM || NewsEM || FDA & CDCEM || Infectious DiseaseHOSP || FDA & CDCHOSP || NewsHOSP || GastroenterologyNews Feed: Internal Medicine News - Gastroenterology